Quick answer
What is Capromorelin?
Built from index records dated 2026-10-09 to 2026-10-13 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk How this site works
Capromorelin is not a peptide, grouped on this site under Growth hormone secretagogues, and the 12 research records kept here are 2 from studies in rats or mice and 10 that do not state what kind of study it is.
The literature search returned 40 records. This site keeps 12 of them, which is 30 per cent of what came back.
What it is
Capromorelin is indexed here despite not being a peptide, because the same research literature and the same searches cover it. This site puts it in the Growth hormone secretagogues group.
A non-peptide ghrelin receptor agonist, described in the retrieved records as a growth hormone secretagogue acting at the ghrelin receptor.[1, 2]
Stated in the titles of the cited 2018 Veterinary Medicine and Science and 2003 Bioorganic and Medicinal Chemistry papers.
What kind of records
The records kept here are animal and laboratory studies only.
That sentence is produced by counting, not by reading. What was counted: no interventional human trial record; 2 rodent and 0 in vitro records among 12.
What this does not settle
- What it does in a body. Counting records is not reading them, and nothing here has been read in full.
- Whether it causes harm. No adverse-effect row was taken from any source for this entry.
- How long it lasts. No pharmacokinetics source was retrieved for this entry.
- What the other 28 retrieved records say. They are not in this index.
The longer explanation
Where this comes from
The records cited above, in full.
- Capromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs. Veterinary medicine and science (2018). pmid:29468076
- Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin. Bioorganic & medicinal chemistry (2003). pmid:12538023